Company research
GB SCIENCES INC
CIK 1165320Updated Sep 27, 2026
SecurityGBLX · OTC · equity
Name history
Growblox Sciences, Inc. · through May 12, 2017Signature Exploration & Production Corp. · through May 9, 2014Diabetic Treatment Centers of America, Inc. · through Mar 6, 2008FLAGSTICK VENTURES INC · through Aug 5, 2004
GBLX price & chart
Loading TradingView…
OTC:GBLX on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2024 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 103,442Source | 352,323Source | 2,549,900Source | 10,806,054Source |
| Property, Plant and Equipment, NetUSD | — | — | 0Source | 25,022Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 11,991Source | 109,912Source | 233,893Source | 793,040Source |
| Assets, CurrentUSD | 103,442Source | 309,504Source | 327,826Source | 3,543,855Source |
| Prepaid Expense and Other Assets, CurrentUSD | 91,451Source | 199,592Source | 93,933Source | 256,251Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 5,417,557Source | 4,759,706Source | 4,332,772Source | 12,279,982Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 40,721Source | 38,187Source | 32,504Source | 31,534Source |
| Additional Paid in CapitalUSD | 104,712,156Source | 104,259,745Source | 102,764,746Source | 102,380,770Source |
| Retained Earnings (Accumulated Deficit)USD | -110,066,992Source | -108,705,315Source | -104,580,122Source | -103,886,232Source |
| Stockholders' Equity Attributable to ParentUSD | -5,314,115Source | -4,407,383Source | -1,782,872Source | -1,473,928Source |
| Liabilities and EquityUSD | 103,442Source | 352,323Source | 2,549,900Source | 10,806,054Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 5,095,557Source | 4,759,706Source | 3,935,464Source | 8,598,448Source |
| Accounts Payable, CurrentUSD | — | — | 1,657,008Source | 1,412,459Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 0Source | 75,628Source | 9,627Source | 957,946Source |
| Short-term InvestmentsUSD | 0Source | 0Source | 0Source | 0Source |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -1,361,677Source | -4,125,194Source | -530,873Source | -3,725,027Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 219,168Source | 17,333Source | 60,667Source | 436,349Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 157,593Source | -20,195Source | 821,253Source | -248,115Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -975,698Source | -1,526,861Source | -1,866,154Source | -2,185,220Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 320,000Source | -31,650Source | 1,450,339Source | 4,655,519Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 557,777Source | 1,434,530Source | -495,925Source | -1,476,432Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -97,921Source | -123,981Source | -911,740Source | 993,867Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 109,912Source | 233,893Source | 793,040Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 0Source | 0Source | 0Source | 241,014Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 219,168Source | 17,333Source | — | — |
| Deconsolidation, Gain (Loss), AmountUSD | — | 0Source | 5,206,208Source | — |
| DepreciationUSD | — | — | 25,775Source | 34,555Source |
| Gain (Loss) on Disposition of AssetsUSD | — | 0Source | -15,639Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | 0Source | 22,405Source | 467,872Source |
| General and Administrative ExpenseUSD | — | 1,672,281Source | 1,868,734Source | 2,001,617Source |
| Impairment of Intangible Assets, Finite-livedUSD | 42,195Source | 2,374,261Source | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | -4,125,194Source | -146,528Source | -3,332,850Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -146,528Source | -3,332,850Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | 0Source | -384,345Source | -392,177Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | — |
| InterestExpenseNonoperatingUSD | 218,973Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -1,361,677Source | -4,125,194Source | -530,873Source | -3,725,027Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -1,639,992Source | -4,125,194Source | -530,873Source | -3,725,027Source |
| Nonoperating Income (Expense)USD | 58,832Source | -2,452,913Source | 1,722,206Source | -1,331,233Source |
| Operating ExpensesUSD | 1,420,509Source | — | — | — |
| Other Nonoperating Income (Expense)USD | 320,000Source | 100,000Source | 9,000Source | — |
| Proceeds from Issuance of Common StockUSD | 0Source | 1,483,350Source | — | — |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | -320,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | 0Source | 0Source | 0Source | — |
| Cost of Goods and Services SoldUSD | 0Source | 0Source | 0Source | — |
| Operating Income (Loss)USD | -1,420,509Source | -1,672,281Source | -1,868,734Source | -2,001,617Source |
| Other Nonoperating Income (Expense)USD | 320,000Source | 100,000Source | 9,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -1,361,677Source | -4,125,194Source | -146,528Source | -3,332,850Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | — |
| Net Income (Loss) Attributable to ParentUSD | -1,361,677Source | -4,125,194Source | -530,873Source | -3,725,027Source |
| Earnings Per Share, BasicUSD per share | 0Source | -0.01Source | 0Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 396,728,680Source | 357,721,189Source | 317,621,942Source | — |
| Interest Expense (non-operating)USD | 218,973Source | — | — | — |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | — | 0Source | 58,277Source | 120,451Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 624Source | 61,660Source | 70,488Source | 47,353Source |
| General and Administrative ExpenseUSD | — | 1,672,281Source | 1,868,734Source | 2,001,617Source |
| Gross ProfitUSD | 0Source | 0Source | 0Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | -4,125,194Source | -146,528Source | -3,332,850Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -146,528Source | -3,332,850Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | -0.01Source | 0Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | 0Source | -384,345Source | -392,177Source |
| Interest ExpenseUSD | — | 178,652Source | 474,768Source | 1,285,460Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -1,639,992Source | -4,125,194Source | -530,873Source | -3,725,027Source |
| Net Income (Loss) from Continuing Operations Available to Common Shareholders, BasicUSD | — | -4,125,194Source | -146,528Source | -3,332,850Source |
| Nonoperating Income (Expense)USD | 58,832Source | -2,452,913Source | 1,722,206Source | -1,331,233Source |
| Operating ExpensesUSD | 1,420,509Source | — | — | — |
| Preferred Stock Dividends and Other AdjustmentsUSD | 278,315Source | — | — | — |
| Research and Development ExpenseUSD | 261,550Source | 490,291Source | 821,321Source | 352,274Source |